United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner

MD 2026 Clinical Laboratories

OIG False Claims

Penalty

$26.3 million

Outcome

OIG enforcement action against United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner for false claims. Penalty: $26.3 million.

Details

United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner — OIG Enforcement (2026)

OIG took enforcement action against United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner in MD in 2026 involving false claims violations in the Clinical Laboratories sector.

Penalty: $26.3 million

Violation types: False Claims
Entity type: Clinical Laboratory
Penalty type: Settlement
Location: MD

Source: United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.

Source: United States Obtains $26M In False Claims Act Judgments Against Laboratory Companies And Their Owner

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works